Bromodomain-containing-protein-4 and cyclin-dependent-kinase-9 inhibitors interact synergistically in vitro and combined treatment reduces post-traumatic osteoarthritis severity in mice

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2021
Source ID
10.1016/j.joca.2020.07.012

Entities

People

  • A.k. Haudenschild
  • B. Doyran
  • Dominik R Haudenschild
  • I.e. Adamopoulos
  • J. Davis
  • J.h.n. Yik
  • Li Han
  • T. Fukui

Organizations

  • National Institutes of Health
  • United States Department of Defense